Refractive Surgery

WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, Jay S. Pepose, MD, PhD, shares an update on some of the ophthalmic agents that Ocuphire Pharma has in the pipeline.

WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, Joaquin De Rojas, MD, discusses early data from patients implanted with the Tecnis Synergy IOL.

WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, Bret L. Fisher, MD, discusses the mechanism of action for a small-aperture IOL.

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, OSN Associate Medical Editor Elizabeth Yeu, MD, FACS, discusses the latest developments in refractive correction, including the EVO Visian ICL and the IC-8 IOL.

Nyxol demonstrated positive results in a pediatric safety trial to reverse pharmacologically induced mydriasis, according to a press release from Ocuphire Pharma.

WASHINGTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Warren Foust, worldwide president of surgical vision for Johnson & Johnson Vision, discusses everything the company has happening at ASCRS.

WASHINGTON — Stable and predictable healing of the epithelium is important for achieving positive refractive surgery outcomes, according to a speaker here.

ORLANDO — In this Healio Video Perspective from Cataract Surgery: Telling It Like It Is, George O. Waring IV, MD, FACS, discusses his top tips for ophthalmologists who want to begin using the ICL from STAAR Surgical.

North American Native individuals had a higher rate of ophthalmic conditions but no coinciding increase in ophthalmic care compared with non-Hispanic white individuals, according to a study published in JAMA Ophthalmology.

WAIKOLOA, Hawaii — Monofocal IOLs remain an important option in cataract surgery, according to a presentation at Hawaiian Eye 2022.